Flow cytometric findings in platelets of patients following allogeneic hematopoietic stem cell transplantation

Bone Marrow Transplantation

Volumn 30, Issue 6, 2002, Pages 381-387

  Pihusch, R ^a   Wegner, H ^a   Salat, C ^a   Pihusch, M ^a   Holler, E ^b   Kolb, H J ^a,c   Hiller, E ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^c INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

Graft versus host reaction; Microparticles; Platelets; Storage pool disease

Indexed keywords

FIBRINOGEN RECEPTOR; CELL SURFACE RECEPTOR; GLYCOPROTEIN; MEPACRINE; THROMBOCYTE RECEPTOR;

ADULT; ALLOTRANSPLANTATION; ARTICLE; BLOOD; CASE CONTROL STUDY; DEGRANULATION; FEMALE; FLOW CYTOMETRY; GRAFT VERSUS HOST REACTION; HEMATOLOGIC DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; SURVIVOR; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOPHILIA; ULTRASTRUCTURE; ANTIGEN BINDING; BINDING SITE; BLEEDING TENDENCY; CELL GRANULE; CLINICAL ARTICLE; CONTROLLED STUDY; DENSE BODY; DISEASE ASSOCIATION; HEMOSTASIS; HUMAN CELL; INTERNALIZATION; LYSOSOME; PRIORITY JOURNAL; STAINING; THROMBOCYTE COUNT; THROMBOCYTE STRUCTURE; THROMBOCYTOPATHY;

ADULT; BLOOD PLATELETS; CASE-CONTROL STUDIES; CELL DEGRANULATION; FEMALE; FLOW CYTOMETRY; GRAFT VS HOST DISEASE; HEMATOLOGIC DISEASES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; PLATELET ACTIVATION; PLATELET MEMBRANE GLYCOPROTEINS; SURVIVORS; THROMBOPHILIA; TRANSPLANTATION, HOMOLOGOUS;

EID: 0036750921     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1703663     Document Type: Article

References (34)

1. George JN, Nurden AT, Phillips DR. Molecular defects in interactions of platelets with the vessel wall. New Engl J Med 1984; 311: 1084-1098.
2. Ginsberg MH, Loftus JC, Plow E. Cytoadhesins, integrins and platelets. Thromb Haemost 1988; 59: 1-6.
3. McEver RP. The clinical significance of platelet membrane glycoproteins. Hematol Oncol Clin North Am 1990; 4: 87-103.
4. Nurden P, Bihour C, Combrie R, Gralnick et al. Glycoprotein Ia-IIa (VLA-2) and glycoprotein Ib-IX complexes are processed independently during thrombin-induced platelet activation. J Lab Clin Med 1994; 124: 579-588.
5. Warkentin TE, Hayward CPM, Boshkov LK et al. Sera from patients with heparin-induced thrombocytopenia generate platelet-derived microparticles with procoagulant activity: an explanation for the thrombotic complications of heparin-induced thrombocytopenia. Blood 1994; 84: 3691-3699.
6. Pihusch R, Salat C, Schmitt E, Göhring P et al. Hemostatic complications in bone marrow transplantation: a retrospective analysis of 447 patients. Transplantation (in press).
7. Michelson AD. Flow cytometry: a clinical test of platelet function. Blood 1996; 87: 4925-4936.
8. Schmitz G, Rothe G, Ruf A et al. European Working Group on Clinical Cell Analysis: Consensus protocol for the flow cytometric characterisation of platelet function. Thromb Haemostasis 1998; 79: 885-896.
9. Abrams CS, Ellison N, Budzynski AZ, Shattil SJ. Direct detection of activated platelets and platelet-derived microparticles in humans. Blood 1990; 75; 128-138.
10. Fukami MH. Dense granule factors. In: Platelets and their Factors. Springer Verlag: Berlin, 1997, pp 419-429.
11. Gawaz MP, Bogner C, Gurland HJ. Flow-cytometric analysis of mepacrine-labelled platelets in patients with end-stage renal failure. Haemostasis 1993; 23: 284-292.
12. Mohri H. Acquired von Willebrand disease and storage pool disease in chronic myelocytic leukemia. Am J Hematol 1986; 22: 391-401.
13. Schafer AI. Bleeding and thrombosis in the myeloproliferative disorders. Blood 1984; 64: 1-12.
14. Carr ME, Hines S, Carr SL et al. Storage pool disease in chronic lymphocytic leukemia: abnormal aggregation and secretion without bleeding. Am J Med Sci 1997; 313: 176-181.
15. Saelman EUM, Nieuwenhuis HK, Hese KM et al. Platelet adhesion to collagen types I through VIII under conditions of stasis and flow is mediated by GPIa/IIa (α2β1-integrin). Blood 1994; 83: 1244-1250.
16. Nieuwenhuis HK, Sakariassen KS, Houdijk WP et al. Deficiency of platelet membrane glycoprotein Ia associated with a decreased platelet adhesion to subendothelium: a defect in platelet spreading. Blood 1986; 68: 692-695.
17. Handa M, Watanabe K, Kawai Y et al. Platelet unresponsiveness to collagen: involvement of glycoprotein Ia-IIa (alpha 2 beta 1 integrin) deficiency associated with a myeloproliferative disorder. Thromb Haemostasis 1995; 73: 521-528.
18. Carlo-Stella C, Tabilio A, Regazzi E et al. Effect of chemotherapy for acute myelogenous leukemia on hematopoietic and fibroblast marrow progenitors. Bone Marrow Transplant 1997; 20: 465-471.
19. Marsh JC, Harhalakis N, Dowding C et al. Recurrent graft failure following syngeneic bone marrow transplantation for aplastic anaemia. Bone Marrow Transplant 1989; 4: 581-585.
20. Savage B, Saldivar E, Ruggeri ZM. Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor. Cell 1996; 84: 289-297.
21. Hourdille P, Heilmann E, Combrie R et al. Thrombin induces a rapid redistribution of glycoprotein Ib-IX complexes within the membrane systems of activated human platelets. Blood 1990; 76: 1503-1513.
22. Michelson AD, Barnard MR. Thrombin-induced changes in platelet membrane glycoproteins Ib, IX, and IIb-IIIa complex. Blood 1987; 70: 1673-1678.
23. Michelson AD, Barnard MR, Hechtman HB et al. In vivo tracking of platelets: circulating degranulated platelets rapidly lose surface P-selectin but continue to circulate and function. Proc Natl Acad Sci USA 1996; 93: 11877-11882.
24. Michelson AD, Barnard M, Krueger LA et al. Circulating monocyte-platelet aggregates are a more sensitive marker of in vivo platelet activation than platelet surface P-selectin. Circulation 2001; 104: 1533-1537.
25. Sullivan K, Agura E, Anasetti C. Chronic graft-versus-host disease in other late complications of bone marrow transplantation. Semin Hematol 1991; 28: 250-259.
26. Hughes M, Hayward CP, Warkentin TE et al. Morphological analysis of microparticle generation in heparin-induced thrombocytopenia. Blood 2000; 96: 188-194.
27. Warner MN, Pavord S, Moore JC et al. Serum-induced platelet procoagulant activity: an assay for the characterization of prothrombotic disorders. J Lab Clin Med 1998; 133: 129-133.
28. Gilbert GE, Sims PJ, Widemer T et al. Platelet-derived microparticles express high affinity receptors for Factor VIII. J Biol Chem 1991; 266: 17261-17268.
29. Sims PJ, Faioni EM, Wiedmer T, Shattil SJ. Complement proteins C5b-9 cause release of membrane vesicles from the platelet surface that are enriched in the membrane receptor for coagulation factor Va and express prothrombinase activity. J Biol Chem 1988; 263: 18205-18212.
30. Barry OP, Practico D, Lawson JA, Fitzgerald GA. Transcellular activation of platelet and endothelial cells by bioactive lipids in platelet microparticles. J Clin Invest 1997; 99: 2118-2127.
31. Galli M, Grassi A, Barbui T. Platelet-derived microvesicles in thrombotic thrombocytopenic purpura and hemolytic uremic syndrome. Thromb Haemostasis 1996; 75: 427-431.
32. Hugel B, Socie G, Toti F et al. Elevated levels of circulating procoagulant microparticles in patients with paroxysmal nocturnal hemoglobinuria and aplastic anemia. Blood 1999; 93: 3451-3456.
33. Mallat Z, Benamer H, Hugel B et al. Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes. Circulation 2000; 101: 841-848.
34. Weber A, Koppen HO, Schror K. Platelet-derived microparticles stimulate coronary artery smooth muscle cell mitogenesis by a PDGF-independent mechanism. Thromb Res 2000; 98: 461-466.